Aptamer-based therapeutics and their potential in radiopharmaceutical design
Aptamers, short, single stranded oligonucleotide entities, have been developed in the past 15 years against a plethora of targets and for a variety of applications. These range from inhibition of receptors and enzymes to the identification of small molecules in sensor applications, and from the deve...
Main Authors: | Catia S. M. Ferreira, Sotiris Missailidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto de Tecnologia do Paraná (Tecpar)
2007-09-01
|
Series: | Brazilian Archives of Biology and Technology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132007000600008 |
Similar Items
-
Aptamer-based radiopharmaceuticals for diagnostic imaging and targeted radiotherapy of epithelial tumors
by: Sotiris Missailidis, et al.
Published: (2008-12-01) -
The Synthesis and Preclinical Investigation of Lactosamine-Based Radiopharmaceuticals for the Detection of Galectin-3-Expressing Melanoma Cells
by: Barbara Gyuricza, et al.
Published: (2022-11-01) -
Design and Prediction of Aptamers Assisted by In Silico Methods
by: Su Jin Lee, et al.
Published: (2023-01-01) -
The Shorter the Better: Reducing Fixed Primer Regions of Oligonucleotide Libraries for Aptamer Selection
by: Weihua Pan, et al.
Published: (2009-03-01) -
Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging
by: Leila Hassanzadeh, et al.
Published: (2018-10-01)